Li Kang Biomedical Co., Ltd. (TPEX:6242)
38.15
+0.15 (0.39%)
Jun 12, 2026, 1:30 PM CST
-11.89% (1Y)
| Market Cap | 1.21B -7.1% |
| Revenue (ttm) | 575.98M -0.2% |
| Net Income | 77.56M -4.7% |
| EPS | 2.44 -4.5% |
| Shares Out | 31.81M |
| PE Ratio | 15.66 |
| Forward PE | n/a |
| Dividend | 2.00 (5.24%) |
| Ex-Dividend Date | Jun 16, 2026 |
| Volume | 14,232 |
| Open | 38.00 |
| Previous Close | 38.00 |
| Day's Range | 38.00 - 38.80 |
| 52-Week Range | 36.60 - 43.70 |
| Beta | -0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |